Expression of SPARC Like Protein 1 (SPARCL1), Extracellular Matrix-associated Protein is Down Regulated in Gastric Adenocarcinoma

Overview

Journal J Gastrointest Oncol

Date 2016 Apr 2

PMID 27034797

Citations 7

Authors

Aniruddha Jakharia

Biswajyoti Borkakoty

Sujay Singh

Affiliations

Soon will be listed here.

Abstract

Background: SPARC-like protein 1 (SPARCL1/Hevin), a member of the SPARC family is defined by the presence of a highly acidic domain-I, a follistatin-like domain, and an extracellular calcium (EC) binding domain. SPARCL1 has been shown to be down-regulated in many types of cancer and may serve as a negative regulator of cell growth and proliferation.

Methods: Both tumor and adjacent normal tissue were collected from patients with gastric adenocarcinoma. Monoclonal antibody developed against recombinant SPARCL1 was used to analyze the expression of SPARCL1 by immunohisto chemical and western blotting (WB) analysis.

Results: The expression of SPARCL1 was found to be significantly lower or negligible in gastric adenocarcinoma tissues in nearly all of the cases in comparison with adjacent normal tissue. This comparison was found to be independent of the patient's age, sex, and stage of cancer.

Conclusions: We postulate that down regulation of SPARCL1 may be related to inactivation of its tumor suppressor functions and might play an important role in the development of gastric adenocarcinoma.

Citing Articles

The homeoprotein HOXB2 limits triple-negative breast carcinogenesis via extracellular matrix remodeling.

Oh J, Kim C, Jeong D, Kim Y, Kim M, Cho J Int J Biol Sci. 2024; 20(3):1045-1063.

PMID: 38322121 PMC: 10845296. DOI: 10.7150/ijbs.88837.

Comprehensive Profiling of Early Neoplastic Gastric Microenvironment Modifications and Biodynamics in Impaired BMP-Signaling FoxL1-Telocytes.

Alfonso A, Pomerleau V, Nicolas V, Raisch J, Jurkovic C, Boisvert F Biomedicines. 2023; 11(1).

PMID: 36672527 PMC: 9856000. DOI: 10.3390/biomedicines11010019.

Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues.

Klingler A, Regensburger D, Tenkerian C, Britzen-Laurent N, Hartmann A, Sturzl M PLoS One. 2020; 15(5):e0233422.

PMID: 32437418 PMC: 7241726. DOI: 10.1371/journal.pone.0233422.

5-Year Survival in Gastric Adenocarcinoma with Epithelial and Stromal Versican Expression.

Sanei M, Mirmosayyeb O, Chehrei A, Ansari J, Saberi E Iran J Pathol. 2019; 14(1):26-32.

PMID: 31531098 PMC: 6708571. DOI: 10.30699/IJP.14.1.26.

SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling.

Ma Y, Xu Y, Li L Exp Ther Med. 2018; 16(4):3195-3201.

PMID: 30233672 PMC: 6143840. DOI: 10.3892/etm.2018.6575.

References

Esposito I, Kayed H, Keleg S, Giese T, Sage E, Schirmacher P . Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer. Neoplasia. 2007; 9(1):8-17. PMC: 1803032. DOI: 10.1593/neo.06646. View

Miner N, Koehler J, Greenaway L . Intraperitoneal injection of mice. Appl Microbiol. 1969; 17(2):250-1. PMC: 377659. DOI: 10.1128/am.17.2.250-251.1969. View

Bendik I, Schraml P, Ludwig C . Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer. Cancer Res. 1998; 58(4):626-9. View

Ringuette M, Rogers I, Varmuza S, Rush S, Brown I . Expression of SC1 is associated with the migration of myotomes along the dermomyotome during somitogenesis in early mouse embryos. Dev Genes Evol. 1998; 208(7):403-6. DOI: 10.1007/s004270050196. View

Kaleagasioglu F, Berger M . SIBLINGs and SPARC families: their emerging roles in pancreatic cancer. World J Gastroenterol. 2014; 20(40):14747-59. PMC: 4209540. DOI: 10.3748/wjg.v20.i40.14747. View

Li P, Qian J, Yu G, Chen Y, Liu K, Li J . Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. J Surg Oncol. 2011; 105(1):31-7. DOI: 10.1002/jso.22025. View

Claeskens A, Ongenae N, Neefs J, Cheyns P, Kaijen P, Cools M . Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. Br J Cancer. 2000; 82(6):1123-30. PMC: 2363342. DOI: 10.1054/bjoc.1999.1051. View

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

STEWARD J, Ornellas E, Beernink K, NORTHWAY W . Errors in the technique of intraperitoneal injection of mice. Appl Microbiol. 1968; 16(9):1418-9. PMC: 547667. DOI: 10.1128/am.16.9.1418-1419.1968. View

10.

Cao F, Wang K, Zhu R, Hu Y, Fang W, Ding H . Clinicopathological significance of reduced SPARCL1 expression in human breast cancer. Asian Pac J Cancer Prev. 2013; 14(1):195-200. DOI: 10.7314/apjcp.2013.14.1.195. View

11.

Chung C, Niemela S, Miller R . One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc Natl Acad Sci U S A. 1989; 86(7):2172-5. PMC: 286873. DOI: 10.1073/pnas.86.7.2172. View

12.

Vial E, Perez S, Castellazzi M . Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors. Oncogene. 2000; 19(43):5020-9. DOI: 10.1038/sj.onc.1203867. View

13.

Milne A, Carneiro F, OMorain C, Offerhaus G . Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009; 126(5):615-28. PMC: 2771140. DOI: 10.1007/s00439-009-0722-x. View

14.

Nelson P, Plymate S, Wang K, True L, Ware J, Gan L . Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. Cancer Res. 1998; 58(2):232-6. View

15.

E Kalume D, Peri S, Reddy R, Zhong J, Okulate M, Kumar N . Genome annotation of Anopheles gambiae using mass spectrometry-derived data. BMC Genomics. 2005; 6:128. PMC: 1249570. DOI: 10.1186/1471-2164-6-128. View

16.

Yan Q, Sage E . SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem. 1999; 47(12):1495-506. DOI: 10.1177/002215549904701201. View

17.

Johnston I, Paladino T, Gurd J, Brown I . Molecular cloning of SC1: a putative brain extracellular matrix glycoprotein showing partial similarity to osteonectin/BM40/SPARC. Neuron. 1990; 4(1):165-76. DOI: 10.1016/0896-6273(90)90452-l. View

18.

Kohler G, Milstein C . Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol. 1976; 6(7):511-9. DOI: 10.1002/eji.1830060713. View

19.

Notterman D, Alon U, Sierk A, Levine A . Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 2001; 61(7):3124-30. View